PledPharma: PledPharma AB: Aladote's data has been selected for presentation at The International Liver Congress

Stockholm, January 31, 2019. PledPharma AB (publ) announces that the abstract on the positive results from the Aladote's Phase Ib/IIa proof of principle-study has been selected for an oral presenta...